Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection
- PMID: 35309736
- PMCID: PMC8916827
- DOI: 10.1016/j.ekir.2022.03.005
Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection
Comment on
-
Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation.Kidney Int Rep. 2022 May;7(5):983-992. doi: 10.1016/j.ekir.2022.01.1072. Epub 2022 Feb 7. Kidney Int Rep. 2022. PMID: 35155848 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
